Menu Search
Equities

Shandong Weigao Group Medical Polymer Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
UK2:FRA

Shandong Weigao Group Medical Polymer Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.530
  • Today's Change-0.05 / -8.62%
  • Shares traded1.06k
  • 1 Year change-8.62%
  • Beta0.6610
Data delayed at least 15 minutes, as of Feb 16 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of medical device products. The Company operates its businesses through six segments. The Medical Device segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The Company mainly operates its businesses in the domestic and overseas markets.

  • Revenue in HKD (TTM)14.83bn
  • Net income in HKD2.23bn
  • Incorporated2000
  • Employees13.06k
  • Location
    Shandong Weigao Group Medical Polymer Co Ltd1 Weigao RoadTorch Hi-tech Science ParkWEIHAI 264210ChinaCHN
  • Phone+86 6 315621999
  • Fax+86 6 315621999
  • Websitehttps://www.weigaoholding.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.